Table 6.
Placebo group (n = 40) | SGE group (n = 40) | p valueb | |||||
---|---|---|---|---|---|---|---|
0 weeks | 12 weeks | p valuea | 0 weeks | 12 weeks | p valuea | ||
TC (mg/dL) | 190.78 ± 31.45 | 196.00 ± 34.51 | 0.304 | 184.40 ± 25.14 | 180.75 ± 27.35 | 0.584 | 0.254 |
TG (mg/dL) | 103.05 ± 45.10 | 113.19 ± 72.30 | 0.418 | 105.43 ± 59.55 | 110.78 ± 69.82 | 0.570 | 0.871 |
LDL-C (mg/dL) | 111.93 ± 27.54 | 115.67 ± 28.71 | 0.351 | 106.15 ± 23.56 | 103.50 ± 22.75 | 0.648 | 0.281 |
HDL-C (mg/dL) | 58.20 ± 12.23 | 58.28 ± 13.75 | 0.978 | 57.10 ± 11.91 | 55.14 ± 9.51 | 0.371 | 0.504 |
Adiponectin (μg/mL) | 8.49 ± 2.65 | 8.18 ± 2.87 | 0.458 | 8.41 ± 3.12 | 7.46 ± 2.69 | 0.034 | 0.173 |
Leptin (ng/mL) | 30.23 ± 10.77 | 36.81 ± 12.89 | 0.002 | 31.08 ± 14.33 | 30.52 ± 15.14 | 0.939 | 0.053 |
Values are presented as mean ± SD
TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol
aAnalyzed by a linear mixed model (differences within a group)
bAnalyzed by a linear mixed model (differences between groups)